Phase 1 Classic Hodgkin Lymphoma Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study of AK129 With or Without AK117 in PD(L)1-refractory Classic Hodgkin Lymphoma
Classic Hodgkin Lymphoma
Akeso280 enrolled1 locationNCT06642792
Recruiting
Phase 1Phase 2
A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies
Triple-Negative Breast CancerOvarian CancerCervical Cancer+7 more
Innolake Biopharm200 enrolled1 locationNCT05955105